CORONAVIRUS/Taiwan receives 1,728 Evusheld doses for immunocompromised people
Taipei, Sept. 8 (CNA) Taiwan has purchased 10,000 doses of Evusheld to provide protection to immunocompromised people at high risk of contracting severe COVID-19, with the first shipment of 1,728 doses having already arrived in the country, according to the Central Epidemic Command Center (CECC) Thursday.
The 1,728 doses of Evusheld, a combination of two monoclonal antibodies -- tixagevimab (AZD8895) and cilgavimab (AZD1061) -- developed by AstraZeneca arrived in Taiwan on Tuesday and will be delivered to medical centers and regional hospitals for conditional use starting Thursday, where they will undergo medical evaluation to determine their safety and efficacy, CECC head Victor Wang (王必勝) said.
Evusheld is a preventive antibody therapy that has shown neutralizing activity against the Omicron BA.2, BA.2.12.1, BA.4, and BA.5 subvariants and is authorized for emergency use as a pre-exposure prophylaxis for COVID-19.
The monoclonal antibodies have received emergency use authorization (EUA) in the United States, France, the United Kingdom, Australia and several countries in Europe as a preventive tool for individuals who cannot get vaccinated or immunocompromised patients before they are exposed to COVID-19.
The Centers for Disease Control has included Evusheld as a recommended drug in its guidelines for clinical management of infection from SARS-CoV-2, the coronavirus that causes COVID-19, and the Evusheld doses will be stored in medical centers and some regional hospitals to be used for eligible people, including patients with congenital immunodeficiencies, the CECC said.
However, the CECC noted that timely vaccination against COVID-19 is still the most effective measure for preventing infection, saying that Evusheld cannot replace vaccination.
As of Wednesday, 93.1 percent of the eligible Taiwanese population had received at least one COVID-19 dose, while 87 percent had gotten two shots and 73.3 percent had received a first booster shot.
About 9.8 percent of the population has received a second booster shot, including 34.9 percent of those aged 65 and above, CECC statistics showed.
- Taiwan's domestic COVID-19 cases continue to surgeDaily domestic COVID-19 cases in Taiwan shot up 11.5 percent week-over-week to reach 43,241 on Sunday, according to the Central Epidemic Command Center (CECC).10/02/2022 07:48 PM
- Taiwan reports 43,307 new COVID-19 cases, 62 deathsTaiwan on Sunday reported 43,307 new cases of COVID-19 and 62 deaths from the disease, according to the Central Epidemic Command Center (CECC).10/02/2022 02:23 PM
- Taiwan reports 43,085 new COVID-19 cases, 48 deathsTaiwan on Saturday reported 43,085 new COVID-19 infections, including 45 imported cases, and 48 deaths from the disease, according to the Central Epidemic Command Center (CECC).10/01/2022 03:20 PM
German parliamentary group to meet with President Tsai, VP Lai10/02/2022 08:52 PM
More than 141,000 free flu shots administered on first day of rollout10/02/2022 08:29 PM
Opera lovers to be treated with 3 productions around Taiwan in October10/02/2022 08:17 PM
Taiwan's domestic COVID-19 cases continue to surge10/02/2022 07:48 PM
Taiwan's military recruitment pool shrinking due to low birth rate: report10/02/2022 07:29 PM